Amarin’s Triglyceride-Lowering Drug Gets Second FDA Nod to Tackle Cardiovascular Disease
A treatment developed by the Irish company Amarin has become the first FDA-approved drug to…
December 16, 2019 - 2 minutes
Cardiovascular disease
German Biotech Raises €7M Series A to Treat Acute Heart Failure
4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of…
December 5, 2019 - 2 minutes
Top Cardiology Biotech News from the ESC Conference 2019
Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest…
September 5, 2019 - 4 minutes
Anti-Aging Gene Therapy Treats Cardiovascular Disease in Mice
A research group in Italy has reduced cardiovascular disease in mice by expressing an anti-aging…
July 10, 2019 - 3 minutes
Microbiome Food Supplement Improves Metabolic Syndrome in Overweight People
A food supplement made from bacteria, developed by a Belgian research group, has improved symptoms…
July 2, 2019 - 3 minutes
Diagnostic Test Beats ‘Bad’ Cholesterol at Predicting Heart Attacks
A study run by the Finnish diagnostics biotech Zora Biosciences has found two biomarkers that…
June 24, 2019 - 2 minutes
Actelion and UK Biotech Collaborate to Detect Heart Failure in Patient’s Breath
Owlstone Medical and the Swiss biotech Actelion have teamed up to co-develop a breathalyzer that…
May 21, 2019 - 2 minutes
Researchers in Israel 3D Print a Personalized Heart from Donor’s Tissue
A group of scientists in Israel is the first to 3D print a vascularized heart…
April 16, 2019 - 3 minutes
Swiss Biotech Raises €8.8M to Progress Regenerative Stroke Treatment
The Swiss company NovaGo has raised €8.8M (CHF 10M) in Series A funding to develop…
March 4, 2019 - 3 minutes
Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease
Novo Nordisk and the Dutch company Staten Biotechnology will partner to develop a treatment to…
December 17, 2018 - 2 minutes
French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins
The French company Quantum Genomics is developing a first-in-class drug that targets proteins in the…
November 13, 2018 - 2 minutes
Series C Bags German Company €17M for Irregular Heartbeat Treatment
Omeicos Therapeutics has secured €17M in a Series C round to fund clinical development of…
November 5, 2018 - 2 minutes
